Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
Phase 2 Completed
17 enrolled 12 charts
COXEN
Phase 2 Completed
237 enrolled 20 charts
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
Phase 2 Completed
39 enrolled 7 charts
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
Phase 3 Completed
330 enrolled
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Completed
490 enrolled
Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
Phase 2 Completed
40 enrolled
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
Phase 3 Completed
21 enrolled
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function
Phase 2 Completed
40 enrolled 7 charts
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
Phase 1 Completed
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Phase 3 Completed
306 enrolled
NMIBCIVT
Phase 4 Completed
240 enrolled
Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)
Phase 2 Completed
40 enrolled 8 charts
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Phase 2 Completed
291 enrolled 18 charts
Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma
Phase 2 Completed
5 enrolled 2 charts
Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2 Completed
47 enrolled
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Phase 2 Completed
80 enrolled 6 charts
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Phase 2 Completed
39 enrolled 7 charts
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Phase 3 Completed
285 enrolled
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Completed
42 enrolled
Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer
Phase 2 Completed
60 enrolled 10 charts
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Phase 3 Completed
350 enrolled
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
Phase 3 Completed
203 enrolled
Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Phase 1 Completed
18 enrolled
Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer
Phase 2 Completed
30 enrolled
Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer
Phase 1/2 Completed
30 enrolled
Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer
Phase 1 Completed
30 enrolled
Doxo
Phase 2 Completed
101 enrolled
Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer
Phase 2 Completed
Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer
Phase 3 Completed
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Phase 2 Completed
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
Phase 2 Completed
65 enrolled
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
Phase 2 Completed
75 enrolled
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
Phase 3 Completed
340 enrolled
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
Phase 1 Completed